Market Updates: Regeneron, UPS, and Zebra
The bear phase for Regeneron (REGN) seems to be over, with shares rebounding from $550-$575 to over $650, a 12% jump, after reporting a 0.8% revenue increase to $3.75 billion.
Regeneron posted strong sales of Dupixent, at $4.9 billion, which offset weak sales from EYLEA, although EYLEA HD sales grew by 42% to $663 million. The firm also lowered its R&D and SG&A expense forecast for the fiscal year.
- UPS, despite being down nearly 25% in 2025, added 8.0% after posting non-GAAP EPS of $1.74 on revenue of $21.4 billion (-3.6% Y/Y).
- The company announced a massive 48,000 job cut, with 34,000 cuts in the operational unit and 14,000 at the management level, leading to a stock market rally.
- Zebra (ZBRA) continued its downtrend, which began in August and accelerated in October, with the stock losing 11%.
No direct quotes available in the provided text.
Author's summary: Market updates on Regeneron, UPS, and Zebra stocks.
More News
- No reported injuries in Cohoes shots fired incident
- Why A-list celebrities are heading to Macao this season
- Stranger Things 5 trailer shows way more than we were ready for
- Trick-or-treaters turn out at Troy Historic Village
- NBA approves $10 billion Lakers sale to Mark Walter
- Shares of Navan Down 16% In Long-Awaited IPO Debut
- O Canada! Summer tourism numbers hit all-time high | RCI
- City Council approves Jamaica Neighborhood Plan, ushering in up to 12,000 new homes – QNS
- Flau’jae Johnson Shuts Down Governor’s Call for Charlie Kirk Statue at LSU, Social Media Rides With Her
- Stranger Things 5 Trailer Unleashes All-Out War in Hawkins Ahead of Final Season! | SPIN1038